Popular Articles
Today Week Month Year






New study sheds light on how Alzheimer’s disease damages the brain
04/19/2019 // Edsel Cook // Views

Researchers claimed to have figured out exactly how amyloid beta and tau proteins harm the brain during the onset and progress of Alzheimer's disease. They urged for therapies that simultaneously target both pathogenic proteins because the structures they formed could interact with each other.

When amyloid beta accumulates in the brain, it forms stiff plaques. Similarly, high levels of tau form structures called neurofibrillary tangles.

"Our current study reinforces growing evidence suggesting that A-beta and tau work together to impair brain function and that, for certain aspects of that impairment, tau predominates," explained Dr. Bradley Hyman, a researcher from the Massachusetts General Hospital (MGH) who served as the primary author of the scientific paper. "We are intrigued to learn how they are interacting at a molecular level, in order to find ways of blocking that synergy."

Hyman and his team ran a number of animal models that simulated Alzheimer's disease in humans. Through the use of multiphoton calcium imaging techniques, they evaluated the activity of neurons in the brain of mice with amyloid beta plaques and neurofibrillary tangles. (Related: Coconut oil studied for its potential to reverse Alzheimer’s.)

Over-expression of tau proteins causes Alzheimer's symptoms

Tests with a mouse model of amyloid beta over-expression reinforced earlier findings that the protein's plaques cause hyperactivity in the neurons. Separate tests with models involving increased expression of different forms of tau showed that higher concentrations of the harmful protein caused neural activity to go down. This applied even if the tau had not yet formed neurofibrillary tangles.

Brighteon.TV

A fourth mouse model simulated the presence of both amyloid beta and tau in large amounts. Tests showed that affected animals displayed decreased levels of brain activity, suggesting that tau's harmful effects took precedence over those caused by amyloid beta.

The mice used in the four models were bred so that their body's production of tau proteins can be stopped if the animals undergo specific treatments. The MGH researchers took advantage of this to determine any correlations between the proteins.

They recorded the neural activity of the mice as a baseline of comparison before treating two groups of animals. Some of the mice produced excessive amounts of both amyloid beta and tau proteins, while others only over-expressed tau.

Six weeks after treatment, the researchers again evaluated the brain activity of the mice. They compared the post-treatment data with the pre-treatment data.

Therapies need to target both amyloid beta and tau proteins

The MGH researchers found that blocking tau expression restored the normal brain activity of mice that over-expressed that protein. This included both young mice with still-developing brains and old specimens that could no longer grow new brain cells.

However, the animals that over-expressed both amyloid beta and tau did not regain their original levels of neural activity, even after receiving the treatment. The signs of neural damage could be seen even in the youngest mice, which should have been able to recover better than their elders.

The researchers believed that their results explained why recent clinical trials of amyloid beta-blocking treatments were not able to effectively alleviate the symptoms of Alzheimer's disease. Those experimental therapies left tau proteins alone, which continued to cause problems in the brain.

"One implication of our work is that approaches combining anti-A-beta and anti-tau therapies might be more effective than either alone, at least from the perspective of neural activation," warned Hyman, who also served as a professor at Harvard Medical School. "Finding that tau and A-beta work in a synergistic fashion opens the doors to new research into understanding exactly how that interaction works."

Sources include:

ScienceDaily.com

Nature.com



Take Action:
Support Natural News by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NaturalNews.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
App Store
Android App
eTrust Pro Certified

This site is part of the Natural News Network © 2022 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
Natural News uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.